Biotechnology Jobs

• Belgium-Wavre
• Hybrid · 2 days in office
• €123,000 – €205,000 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, owning the epidemiology plan for at least one asset or disease area. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory teams, and manages external partnerships while mentoring junior scientists.

Electronic Health Records · Claims Data · Registries

• Durham, United States
• US$148,500 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Establishes KPIs and reporting to track strategy impact and mitigate network risk.

• Stevenage
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director · manages people

Provides clinical and scientific leadership across early-phase cardiovascular programs, shaping clinical development plans, study designs and regulatory documents. Leads a cross-functional Clinical Matrix Team, oversees medical monitoring and safety, and acts as the clinical point of contact for regulators, investigators and key external experts. Hybrid role with at least two days per week on-site.

• Waltham, United States
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires close collaboration across a matrix and deep knowledge of real-world data sources and payer needs.

• London
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies across oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing, while building knowledge of real-world data sources and payer needs.

• Rockville Tower Oaks Blvd
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and delivery of real-world evidence and health outcomes studies across oncology assets, managing protocols, budgets, timelines and vendor deliverables. Partners with medical, market access, R&D and commercial teams plus external experts to shape evidence for HTA submissions, reimbursement and value-based pricing. Requires deep knowledge of RWD sources and payer evidence requirements.

• Durham Blackwell Street
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and delivery of real-world evidence and health outcomes studies for oncology assets, managing protocols, budgets, vendors and reporting from concept to publication. Advises medical, market access and commercial teams on payer and HTA evidence needs, and builds relationships with external experts and data partners.

• London
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.

• Waltham, United States
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds relationships with key external experts and represents the company at advisory boards and medical meetings.

• Stevenage
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

• Zug, Switzerland
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

• Waltham, United States
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director · manages people

Provides clinical and scientific leadership across early-phase clinical development programs in GSK's Respiratory, Immunology & Inflammation Research Unit, focusing on aging. Leads the Clinical Matrix Team, designs clinical development plans and study protocols, oversees medical monitoring and safety, and represents programs in regulatory interactions. Works cross-functionally with biology, translational sciences, commercial, and regulatory partners.

• Stevenage
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director · manages people

Provides clinical and scientific leadership across translational and clinical studies within GSK's Respiratory, Immunology & Inflammation Research Unit, with a focus on aging. Leads a Clinical Matrix Team, designs clinical development plans and protocols, and oversees medical monitoring, safety and regulatory interactions. Hybrid working with at least two days per week on-site, initially in Stevenage before a planned relocation to Cambridge, UK.

• London
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director · manages people

Provides clinical and scientific leadership across early-phase clinical development programs in GSK's Respiratory, Immunology & Inflammation Research Unit, with a focus on aging research. Leads a Clinical Matrix Team, designs clinical development plans and study protocols, oversees medical monitoring and safety, and represents programs in regulatory interactions. Works cross-functionally with biology, translational sciences, commercial, regulatory and statistics partners.

• Stevenage
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

AI/ML